eee)
eC ad
Lawrence Blonde, MD, FACP, MACE
eA ee ned
ere)
Samuel Dagogo-fack, MD. FACE
eae
AACE/ACE COMPREHENSIVE TYPE 2
DIABETES MANAGEMENT ALGORITHM
——— | lll Le
TASK FORCE
Ucar eRe
Daniel Einhorn, MD, FACP, FACE
amd
ead
SL aa red
Ce et ea ees
Se a eta
Pee)
Ce aed
ceed
Jeffrey Mechanick, MD, FACP, FACE, FACN, ECNU
Pree need
cmdLesyle therapy, including medically supervised weight os, key to managing type 2 dabetes.
Wilght loss should be considered as a ielong goal nal patients with predlabetes and T20 who aso have overweight or
best, tlizing behavioral interventions and weight loss medeations a required to achieve chronic therapeutic goat
‘The AIC target ust be individualized
Glycemic contrat targetsinciud fasting and postpranal glucoes
‘The choice of therapies must be individualized on bai of patient characteristics, impact of net cost te patient, formulary
restntions, personal preferences, tc
Minimizing risk of hypoalycemials a pony
Minimizing rik of weight gains 2 riety
Intl acquisition cost of medications i only part ofthe total cost of cae which includes monitoring eaurements,
tak of rypogiyema, weight gain, safety ee
This algo stratifies cole of therapies based on nal ATC
Combination therapy is usualy required and should involve agents with complementary ations
Comprehensive management includes ipl and blood presure therapies and related comerbicite,
‘Therapy mustbe evaluated frequently untl stable eg, every 3 months) and then les often.
The therapeutic regimen should be as simple as possible to optimize adherence.
‘This algrthm includes every FOR approved das of medications for dabetes.STATIN THERAPY
eae nee Ee
‘ry alternate statin, ower statin Repeatipid pane Intensy therapies to
dose or frequency of add nonstatin assesacequacy, stain goals seording
LOL lowering therapies tolerance of therapy Torisklevel
peat
LOLCat 100 70 <
Non HOU maya) 0 0 eS
p08 nai) = 6.5%
For patients without For patients with
concurrent serious concurrent serious
illness and at low illness and at risk
hypoglycemic risk for hypoglycemiaLGORITHM
aS AS re
luding Medically Assisted Weight Li
Ea _ =
fecnie ee
Y Metformin LL ETA ee Sia
vy GLPALRA +
4% aie Ae = orother fy T2D.
¥ Bromocriptine QR ot colaseel
em
Saetediame| cts
v AGL INSULIN
ffeil Algorithm
Ly suai
ia ace =Ay
TDD 0.1-0.2 U/kg JM TDD 0.2-0.3 U/kg
eee
ree
Ss
oie
£3
rr} Add Prandial Insulin
Cary
Ec]
Cr
See
ites
Becin prandial Begin randil
largest meal each meal
If notat goal 50% Basal
progres to 50% Prandial
Injections before 1000305 Ug
Zor imeals
enn eee ee
See eePROFILES OF ANTIDIABETIC MEDICATIONS 7%
COLSVL BCR-QR INSULIN. PRAML
cr) er Newrat | Neue! | News Per ee nd oe
Welch stighttass| Los Loss fe od Gain | Newwat | newiat | Gai Loss
[ co
, [ pore
roe cee] Peer re
RENAL/GU ee ee Oe eC ee
ecvein Ue
cern
ossble | possible Benetor | Nbumunura
ried ica
roy roa} re rey
Poa - ae ee
Feri ice ik | Nowa! | Newt | Ri
ARDIAC: cor Por es co
oy etal oid
ree} >
Cv bene pay Bee
BONE Pe srt Pere) Neural | Newral | newtal | Neural | Newtat
xeroaciooss aa or ce ko)